Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares rose 1.5% during trading on Friday . The company traded as high as GBX 8.25 ($0.10) and last traded at GBX 8.25 ($0.10). Approximately 29,881 shares were traded during trading, a decline of 91% from the average daily volume of 331,950 shares. The stock had previously closed at GBX 8.13 ($0.10).
Ondine Biomedical Trading Up 1.5 %
The company has a market cap of £22.88 million, a PE ratio of -275.00 and a beta of 0.10. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37. The business’s 50-day simple moving average is GBX 7.23 and its 200-day simple moving average is GBX 7.45.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Read More
- Five stocks we like better than Ondine Biomedical
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Why is the Ex-Dividend Date Significant to Investors?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Health Care Stocks Explained: Why You Might Want to Invest
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
